SynthesisCurrent cancer drug targets2024

Efficacy and Safety of Phosphatidylinositol 3-kinase Inhibitors for Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Yi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.